nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—CYP2E1—lung cancer	0.47	1	CbGaD
Orphenadrine—CYP2B6—Irinotecan—lung cancer	0.0342	0.132	CbGbCtD
Orphenadrine—CYP2B6—Cisplatin—lung cancer	0.0279	0.107	CbGbCtD
Orphenadrine—CYP2E1—Etoposide—lung cancer	0.0278	0.107	CbGbCtD
Orphenadrine—CYP3A4—Topotecan—lung cancer	0.0215	0.0827	CbGbCtD
Orphenadrine—CYP3A4—Gefitinib—lung cancer	0.0197	0.0757	CbGbCtD
Orphenadrine—CYP3A4—Teniposide—lung cancer	0.0191	0.0734	CbGbCtD
Orphenadrine—CYP2B6—Doxorubicin—lung cancer	0.0187	0.0719	CbGbCtD
Orphenadrine—CYP3A4—Vinorelbine—lung cancer	0.0152	0.0583	CbGbCtD
Orphenadrine—CYP3A4—Crizotinib—lung cancer	0.0121	0.0464	CbGbCtD
Orphenadrine—CYP3A4—Erlotinib—lung cancer	0.0116	0.0447	CbGbCtD
Orphenadrine—CYP3A4—Paclitaxel—lung cancer	0.0107	0.041	CbGbCtD
Orphenadrine—CYP3A4—Irinotecan—lung cancer	0.0105	0.0404	CbGbCtD
Orphenadrine—CYP3A4—Vinblastine—lung cancer	0.00934	0.0359	CbGbCtD
Orphenadrine—CYP3A4—Etoposide—lung cancer	0.00842	0.0324	CbGbCtD
Orphenadrine—CYP3A4—Docetaxel—lung cancer	0.0077	0.0296	CbGbCtD
Orphenadrine—CYP3A4—Doxorubicin—lung cancer	0.00574	0.0221	CbGbCtD
Orphenadrine—Aplastic anaemia—Vinorelbine—lung cancer	0.00148	0.0174	CcSEcCtD
Orphenadrine—Vision blurred—Crizotinib—lung cancer	0.00138	0.0163	CcSEcCtD
Orphenadrine—Levomethadyl Acetate—CHRNB4—lung cancer	0.00122	0.197	CrCbGaD
Orphenadrine—Skin disorder—Crizotinib—lung cancer	0.00116	0.0137	CcSEcCtD
Orphenadrine—Anaphylactic shock—Pemetrexed—lung cancer	0.0011	0.0129	CcSEcCtD
Orphenadrine—Skin disorder—Pemetrexed—lung cancer	0.00106	0.0125	CcSEcCtD
Orphenadrine—Skin disorder—Gefitinib—lung cancer	0.00106	0.0124	CcSEcCtD
Orphenadrine—Constipation—Crizotinib—lung cancer	0.00102	0.0121	CcSEcCtD
Orphenadrine—Agitation—Teniposide—lung cancer	0.000999	0.0118	CcSEcCtD
Orphenadrine—Constipation—Pemetrexed—lung cancer	0.000937	0.011	CcSEcCtD
Orphenadrine—Constipation—Gefitinib—lung cancer	0.000931	0.011	CcSEcCtD
Orphenadrine—Confusional state—Teniposide—lung cancer	0.000894	0.0105	CcSEcCtD
Orphenadrine—Urticaria—Pemetrexed—lung cancer	0.00087	0.0102	CcSEcCtD
Orphenadrine—Tachycardia—Teniposide—lung cancer	0.000866	0.0102	CcSEcCtD
Orphenadrine—Urticaria—Gefitinib—lung cancer	0.000865	0.0102	CcSEcCtD
Orphenadrine—Asthenia—Crizotinib—lung cancer	0.00086	0.0101	CcSEcCtD
Orphenadrine—Levomethadyl Acetate—CHRNA3—lung cancer	0.000846	0.136	CrCbGaD
Orphenadrine—Hypersensitivity—Pemetrexed—lung cancer	0.000807	0.0095	CcSEcCtD
Orphenadrine—Hypersensitivity—Gefitinib—lung cancer	0.000802	0.00944	CcSEcCtD
Orphenadrine—Dizziness—Crizotinib—lung cancer	0.000792	0.00933	CcSEcCtD
Orphenadrine—Asthenia—Pemetrexed—lung cancer	0.000786	0.00925	CcSEcCtD
Orphenadrine—Asthenia—Gefitinib—lung cancer	0.000781	0.00919	CcSEcCtD
Orphenadrine—Pruritus—Pemetrexed—lung cancer	0.000775	0.00912	CcSEcCtD
Orphenadrine—Pruritus—Gefitinib—lung cancer	0.00077	0.00906	CcSEcCtD
Orphenadrine—Vomiting—Crizotinib—lung cancer	0.000762	0.00897	CcSEcCtD
Orphenadrine—Feeling abnormal—Teniposide—lung cancer	0.000731	0.00861	CcSEcCtD
Orphenadrine—Dizziness—Pemetrexed—lung cancer	0.000724	0.00853	CcSEcCtD
Orphenadrine—Nausea—Crizotinib—lung cancer	0.000712	0.00838	CcSEcCtD
Orphenadrine—Urticaria—Teniposide—lung cancer	0.000705	0.0083	CcSEcCtD
Orphenadrine—Vomiting—Pemetrexed—lung cancer	0.000696	0.0082	CcSEcCtD
Orphenadrine—Vomiting—Gefitinib—lung cancer	0.000692	0.00814	CcSEcCtD
Orphenadrine—Anaphylactic shock—Topotecan—lung cancer	0.000658	0.00774	CcSEcCtD
Orphenadrine—Hypersensitivity—Teniposide—lung cancer	0.000654	0.00769	CcSEcCtD
Orphenadrine—Nausea—Pemetrexed—lung cancer	0.000651	0.00766	CcSEcCtD
Orphenadrine—Nausea—Gefitinib—lung cancer	0.000646	0.00761	CcSEcCtD
Orphenadrine—Skin disorder—Topotecan—lung cancer	0.000639	0.00752	CcSEcCtD
Orphenadrine—Asthenia—Teniposide—lung cancer	0.000636	0.00749	CcSEcCtD
Orphenadrine—Skin disorder—Erlotinib—lung cancer	0.000632	0.00744	CcSEcCtD
Orphenadrine—Pruritus—Teniposide—lung cancer	0.000628	0.00739	CcSEcCtD
Orphenadrine—Palpitations—Vinorelbine—lung cancer	0.000609	0.00717	CcSEcCtD
Orphenadrine—Aplastic anaemia—Methotrexate—lung cancer	0.000608	0.00716	CcSEcCtD
Orphenadrine—Constipation—Vinblastine—lung cancer	0.000579	0.00681	CcSEcCtD
Orphenadrine—Vomiting—Teniposide—lung cancer	0.000564	0.00664	CcSEcCtD
Orphenadrine—Anaphylactic shock—Vinorelbine—lung cancer	0.000562	0.00662	CcSEcCtD
Orphenadrine—Constipation—Topotecan—lung cancer	0.000562	0.00662	CcSEcCtD
Orphenadrine—Feeling abnormal—Vinblastine—lung cancer	0.000558	0.00657	CcSEcCtD
Orphenadrine—Constipation—Erlotinib—lung cancer	0.000556	0.00655	CcSEcCtD
Orphenadrine—Headache—Teniposide—lung cancer	0.000556	0.00654	CcSEcCtD
Orphenadrine—Tachycardia—Vinorelbine—lung cancer	0.000549	0.00646	CcSEcCtD
Orphenadrine—Skin disorder—Vinorelbine—lung cancer	0.000546	0.00643	CcSEcCtD
Orphenadrine—Feeling abnormal—Topotecan—lung cancer	0.000542	0.00638	CcSEcCtD
Orphenadrine—Nausea—Teniposide—lung cancer	0.000527	0.0062	CcSEcCtD
Orphenadrine—Aplastic anaemia—Doxorubicin—lung cancer	0.000527	0.0062	CcSEcCtD
Orphenadrine—Urticaria—Topotecan—lung cancer	0.000522	0.00615	CcSEcCtD
Orphenadrine—Hypersensitivity—Vinblastine—lung cancer	0.000499	0.00587	CcSEcCtD
Orphenadrine—Vision blurred—Cisplatin—lung cancer	0.000486	0.00573	CcSEcCtD
Orphenadrine—Asthenia—Vinblastine—lung cancer	0.000486	0.00572	CcSEcCtD
Orphenadrine—Hypersensitivity—Topotecan—lung cancer	0.000484	0.0057	CcSEcCtD
Orphenadrine—Tremor—Cisplatin—lung cancer	0.000484	0.00569	CcSEcCtD
Orphenadrine—Constipation—Vinorelbine—lung cancer	0.000481	0.00566	CcSEcCtD
Orphenadrine—Asthenia—Topotecan—lung cancer	0.000472	0.00555	CcSEcCtD
Orphenadrine—Confusional state—Irinotecan—lung cancer	0.000468	0.00551	CcSEcCtD
Orphenadrine—Asthenia—Erlotinib—lung cancer	0.000467	0.00549	CcSEcCtD
Orphenadrine—Pruritus—Topotecan—lung cancer	0.000465	0.00548	CcSEcCtD
Orphenadrine—Anaphylactic shock—Irinotecan—lung cancer	0.000464	0.00546	CcSEcCtD
Orphenadrine—Feeling abnormal—Vinorelbine—lung cancer	0.000464	0.00546	CcSEcCtD
Orphenadrine—Pruritus—Erlotinib—lung cancer	0.00046	0.00542	CcSEcCtD
Orphenadrine—Tension—Paclitaxel—lung cancer	0.000455	0.00535	CcSEcCtD
Orphenadrine—Anaphylactic shock—Gemcitabine—lung cancer	0.000452	0.00532	CcSEcCtD
Orphenadrine—Dizziness—Vinblastine—lung cancer	0.000448	0.00527	CcSEcCtD
Orphenadrine—Urticaria—Vinorelbine—lung cancer	0.000447	0.00526	CcSEcCtD
Orphenadrine—Skin disorder—Gemcitabine—lung cancer	0.000439	0.00517	CcSEcCtD
Orphenadrine—Vision blurred—Paclitaxel—lung cancer	0.000437	0.00514	CcSEcCtD
Orphenadrine—Dizziness—Topotecan—lung cancer	0.000435	0.00512	CcSEcCtD
Orphenadrine—Tremor—Paclitaxel—lung cancer	0.000434	0.00511	CcSEcCtD
Orphenadrine—Vomiting—Vinblastine—lung cancer	0.00043	0.00507	CcSEcCtD
Orphenadrine—Dizziness—Erlotinib—lung cancer	0.00043	0.00506	CcSEcCtD
Orphenadrine—Agitation—Paclitaxel—lung cancer	0.000426	0.00501	CcSEcCtD
Orphenadrine—Headache—Vinblastine—lung cancer	0.000424	0.00499	CcSEcCtD
Orphenadrine—Anaphylactic shock—Cisplatin—lung cancer	0.000421	0.00496	CcSEcCtD
Orphenadrine—Vomiting—Topotecan—lung cancer	0.000418	0.00492	CcSEcCtD
Orphenadrine—Hypersensitivity—Vinorelbine—lung cancer	0.000414	0.00488	CcSEcCtD
Orphenadrine—Vomiting—Erlotinib—lung cancer	0.000414	0.00487	CcSEcCtD
Orphenadrine—Somnolence—Irinotecan—lung cancer	0.000412	0.00485	CcSEcCtD
Orphenadrine—Headache—Topotecan—lung cancer	0.000412	0.00485	CcSEcCtD
Orphenadrine—Tachycardia—Cisplatin—lung cancer	0.000411	0.00484	CcSEcCtD
Orphenadrine—Palpitations—Paclitaxel—lung cancer	0.00041	0.00482	CcSEcCtD
Orphenadrine—Skin disorder—Cisplatin—lung cancer	0.000409	0.00482	CcSEcCtD
Orphenadrine—Headache—Erlotinib—lung cancer	0.000408	0.0048	CcSEcCtD
Orphenadrine—Asthenia—Vinorelbine—lung cancer	0.000404	0.00475	CcSEcCtD
Orphenadrine—Nausea—Vinblastine—lung cancer	0.000402	0.00473	CcSEcCtD
Orphenadrine—Somnolence—Gemcitabine—lung cancer	0.000402	0.00473	CcSEcCtD
Orphenadrine—Pruritus—Vinorelbine—lung cancer	0.000398	0.00468	CcSEcCtD
Orphenadrine—Constipation—Irinotecan—lung cancer	0.000397	0.00467	CcSEcCtD
Orphenadrine—Nausea—Topotecan—lung cancer	0.000391	0.0046	CcSEcCtD
Orphenadrine—Confusional state—Etoposide—lung cancer	0.000389	0.00458	CcSEcCtD
Orphenadrine—Constipation—Gemcitabine—lung cancer	0.000386	0.00455	CcSEcCtD
Orphenadrine—Nausea—Erlotinib—lung cancer	0.000386	0.00455	CcSEcCtD
Orphenadrine—Anaphylactic shock—Etoposide—lung cancer	0.000386	0.00454	CcSEcCtD
Orphenadrine—Feeling abnormal—Irinotecan—lung cancer	0.000382	0.0045	CcSEcCtD
Orphenadrine—Confusional state—Paclitaxel—lung cancer	0.000381	0.00449	CcSEcCtD
Orphenadrine—Anaphylactic shock—Paclitaxel—lung cancer	0.000378	0.00445	CcSEcCtD
Orphenadrine—Tachycardia—Etoposide—lung cancer	0.000377	0.00443	CcSEcCtD
Orphenadrine—Skin disorder—Etoposide—lung cancer	0.000375	0.00441	CcSEcCtD
Orphenadrine—Feeling abnormal—Gemcitabine—lung cancer	0.000372	0.00438	CcSEcCtD
Orphenadrine—Dizziness—Vinorelbine—lung cancer	0.000372	0.00438	CcSEcCtD
Orphenadrine—Toremifene—CYP1A1—lung cancer	0.000371	0.0597	CrCbGaD
Orphenadrine—Tachycardia—Paclitaxel—lung cancer	0.000369	0.00435	CcSEcCtD
Orphenadrine—Skin disorder—Paclitaxel—lung cancer	0.000367	0.00433	CcSEcCtD
Orphenadrine—Drowsiness—Methotrexate—lung cancer	0.000362	0.00427	CcSEcCtD
Orphenadrine—Vomiting—Vinorelbine—lung cancer	0.000358	0.00421	CcSEcCtD
Orphenadrine—Headache—Vinorelbine—lung cancer	0.000352	0.00415	CcSEcCtD
Orphenadrine—Palpitations—Docetaxel—lung cancer	0.000347	0.00409	CcSEcCtD
Orphenadrine—Feeling abnormal—Cisplatin—lung cancer	0.000347	0.00409	CcSEcCtD
Orphenadrine—Somnolence—Etoposide—lung cancer	0.000343	0.00404	CcSEcCtD
Orphenadrine—Hypersensitivity—Irinotecan—lung cancer	0.000342	0.00402	CcSEcCtD
Orphenadrine—Somnolence—Paclitaxel—lung cancer	0.000336	0.00396	CcSEcCtD
Orphenadrine—Nausea—Vinorelbine—lung cancer	0.000334	0.00393	CcSEcCtD
Orphenadrine—Asthenia—Irinotecan—lung cancer	0.000333	0.00392	CcSEcCtD
Orphenadrine—Constipation—Etoposide—lung cancer	0.00033	0.00388	CcSEcCtD
Orphenadrine—Asthenia—Gemcitabine—lung cancer	0.000324	0.00382	CcSEcCtD
Orphenadrine—Constipation—Paclitaxel—lung cancer	0.000324	0.00381	CcSEcCtD
Orphenadrine—Confusional state—Docetaxel—lung cancer	0.000323	0.00381	CcSEcCtD
Orphenadrine—Anaphylactic shock—Docetaxel—lung cancer	0.000321	0.00377	CcSEcCtD
Orphenadrine—Pruritus—Gemcitabine—lung cancer	0.00032	0.00376	CcSEcCtD
Orphenadrine—Feeling abnormal—Etoposide—lung cancer	0.000318	0.00374	CcSEcCtD
Orphenadrine—Drowsiness—Doxorubicin—lung cancer	0.000314	0.00369	CcSEcCtD
Orphenadrine—Tachycardia—Docetaxel—lung cancer	0.000313	0.00368	CcSEcCtD
Orphenadrine—Feeling abnormal—Paclitaxel—lung cancer	0.000312	0.00367	CcSEcCtD
Orphenadrine—Skin disorder—Docetaxel—lung cancer	0.000311	0.00367	CcSEcCtD
Orphenadrine—Hypersensitivity—Cisplatin—lung cancer	0.00031	0.00365	CcSEcCtD
Orphenadrine—Dizziness—Irinotecan—lung cancer	0.000307	0.00361	CcSEcCtD
Orphenadrine—Urticaria—Etoposide—lung cancer	0.000307	0.00361	CcSEcCtD
Orphenadrine—Asthenia—Cisplatin—lung cancer	0.000302	0.00356	CcSEcCtD
Orphenadrine—Urticaria—Paclitaxel—lung cancer	0.000301	0.00354	CcSEcCtD
Orphenadrine—Vomiting—Irinotecan—lung cancer	0.000295	0.00347	CcSEcCtD
Orphenadrine—Headache—Irinotecan—lung cancer	0.000291	0.00342	CcSEcCtD
Orphenadrine—Vomiting—Gemcitabine—lung cancer	0.000287	0.00338	CcSEcCtD
Orphenadrine—Somnolence—Docetaxel—lung cancer	0.000285	0.00336	CcSEcCtD
Orphenadrine—Hypersensitivity—Etoposide—lung cancer	0.000284	0.00335	CcSEcCtD
Orphenadrine—Headache—Gemcitabine—lung cancer	0.000283	0.00333	CcSEcCtD
Orphenadrine—Hypersensitivity—Paclitaxel—lung cancer	0.000279	0.00328	CcSEcCtD
Orphenadrine—Asthenia—Etoposide—lung cancer	0.000277	0.00326	CcSEcCtD
Orphenadrine—Nausea—Irinotecan—lung cancer	0.000276	0.00324	CcSEcCtD
Orphenadrine—Constipation—Docetaxel—lung cancer	0.000274	0.00323	CcSEcCtD
Orphenadrine—Pruritus—Etoposide—lung cancer	0.000273	0.00321	CcSEcCtD
Orphenadrine—Asthenia—Paclitaxel—lung cancer	0.000271	0.0032	CcSEcCtD
Orphenadrine—Nausea—Gemcitabine—lung cancer	0.000268	0.00316	CcSEcCtD
Orphenadrine—Vomiting—Cisplatin—lung cancer	0.000268	0.00315	CcSEcCtD
Orphenadrine—Pruritus—Paclitaxel—lung cancer	0.000268	0.00315	CcSEcCtD
Orphenadrine—Warfarin—CYP1A1—lung cancer	0.000267	0.043	CrCbGaD
Orphenadrine—Carbinoxamine—CYP2E1—lung cancer	0.000267	0.043	CrCbGaD
Orphenadrine—Vision blurred—Methotrexate—lung cancer	0.000267	0.00314	CcSEcCtD
Orphenadrine—Feeling abnormal—Docetaxel—lung cancer	0.000264	0.00311	CcSEcCtD
Orphenadrine—Dizziness—Etoposide—lung cancer	0.000255	0.003	CcSEcCtD
Orphenadrine—Dizziness—Paclitaxel—lung cancer	0.00025	0.00295	CcSEcCtD
Orphenadrine—Nausea—Cisplatin—lung cancer	0.00025	0.00294	CcSEcCtD
Orphenadrine—Reboxetine—ABCB1—lung cancer	0.000248	0.04	CrCbGaD
Orphenadrine—Vomiting—Etoposide—lung cancer	0.000245	0.00289	CcSEcCtD
Orphenadrine—Headache—Etoposide—lung cancer	0.000242	0.00285	CcSEcCtD
Orphenadrine—Tension—Doxorubicin—lung cancer	0.000241	0.00283	CcSEcCtD
Orphenadrine—Vomiting—Paclitaxel—lung cancer	0.000241	0.00283	CcSEcCtD
Orphenadrine—Headache—Paclitaxel—lung cancer	0.000237	0.00279	CcSEcCtD
Orphenadrine—Hypersensitivity—Docetaxel—lung cancer	0.000236	0.00278	CcSEcCtD
Orphenadrine—Confusional state—Methotrexate—lung cancer	0.000233	0.00274	CcSEcCtD
Orphenadrine—Brompheniramine—CYP2E1—lung cancer	0.000231	0.0373	CrCbGaD
Orphenadrine—Anaphylactic shock—Methotrexate—lung cancer	0.000231	0.00272	CcSEcCtD
Orphenadrine—Vision blurred—Doxorubicin—lung cancer	0.000231	0.00272	CcSEcCtD
Orphenadrine—Asthenia—Docetaxel—lung cancer	0.00023	0.00271	CcSEcCtD
Orphenadrine—Nausea—Etoposide—lung cancer	0.000229	0.0027	CcSEcCtD
Orphenadrine—Pruritus—Docetaxel—lung cancer	0.000227	0.00267	CcSEcCtD
Orphenadrine—Agitation—Doxorubicin—lung cancer	0.000225	0.00265	CcSEcCtD
Orphenadrine—Nausea—Paclitaxel—lung cancer	0.000225	0.00265	CcSEcCtD
Orphenadrine—Skin disorder—Methotrexate—lung cancer	0.000224	0.00264	CcSEcCtD
Orphenadrine—Fenoprofen—PTGS2—lung cancer	0.000218	0.0352	CrCbGaD
Orphenadrine—Palpitations—Doxorubicin—lung cancer	0.000217	0.00255	CcSEcCtD
Orphenadrine—Dizziness—Docetaxel—lung cancer	0.000212	0.0025	CcSEcCtD
Orphenadrine—Tamoxifen—CYP2A6—lung cancer	0.000211	0.034	CrCbGaD
Orphenadrine—Somnolence—Methotrexate—lung cancer	0.000205	0.00242	CcSEcCtD
Orphenadrine—Vomiting—Docetaxel—lung cancer	0.000204	0.0024	CcSEcCtD
Orphenadrine—Confusional state—Doxorubicin—lung cancer	0.000202	0.00238	CcSEcCtD
Orphenadrine—Headache—Docetaxel—lung cancer	0.000201	0.00236	CcSEcCtD
Orphenadrine—Anaphylactic shock—Doxorubicin—lung cancer	0.0002	0.00236	CcSEcCtD
Orphenadrine—Toremifene—ABCB1—lung cancer	0.000197	0.0317	CrCbGaD
Orphenadrine—Tachycardia—Doxorubicin—lung cancer	0.000195	0.0023	CcSEcCtD
Orphenadrine—Fenoprofen—ALB—lung cancer	0.000195	0.0313	CrCbGaD
Orphenadrine—Skin disorder—Doxorubicin—lung cancer	0.000194	0.00229	CcSEcCtD
Orphenadrine—Nausea—Docetaxel—lung cancer	0.00019	0.00224	CcSEcCtD
Orphenadrine—Feeling abnormal—Methotrexate—lung cancer	0.00019	0.00224	CcSEcCtD
Orphenadrine—Tamoxifen—ABCG2—lung cancer	0.000189	0.0304	CrCbGaD
Orphenadrine—Urticaria—Methotrexate—lung cancer	0.000184	0.00216	CcSEcCtD
Orphenadrine—Somnolence—Doxorubicin—lung cancer	0.000178	0.00209	CcSEcCtD
Orphenadrine—Constipation—Doxorubicin—lung cancer	0.000171	0.00201	CcSEcCtD
Orphenadrine—Hypersensitivity—Methotrexate—lung cancer	0.00017	0.002	CcSEcCtD
Orphenadrine—Phenprocoumon—ALB—lung cancer	0.000168	0.027	CrCbGaD
Orphenadrine—Asthenia—Methotrexate—lung cancer	0.000166	0.00195	CcSEcCtD
Orphenadrine—Feeling abnormal—Doxorubicin—lung cancer	0.000165	0.00194	CcSEcCtD
Orphenadrine—Pruritus—Methotrexate—lung cancer	0.000164	0.00192	CcSEcCtD
Orphenadrine—Fluoxetine—ALB—lung cancer	0.000163	0.0263	CrCbGaD
Orphenadrine—Urticaria—Doxorubicin—lung cancer	0.000159	0.00187	CcSEcCtD
Orphenadrine—Fluoxetine—ABCB1—lung cancer	0.000156	0.0251	CrCbGaD
Orphenadrine—Dizziness—Methotrexate—lung cancer	0.000153	0.0018	CcSEcCtD
Orphenadrine—Tamoxifen—CYP2E1—lung cancer	0.00015	0.0242	CrCbGaD
Orphenadrine—Warfarin—ALB—lung cancer	0.000149	0.024	CrCbGaD
Orphenadrine—Tamoxifen—CYP1A1—lung cancer	0.000148	0.0238	CrCbGaD
Orphenadrine—Hypersensitivity—Doxorubicin—lung cancer	0.000147	0.00174	CcSEcCtD
Orphenadrine—Vomiting—Methotrexate—lung cancer	0.000147	0.00173	CcSEcCtD
Orphenadrine—Headache—Methotrexate—lung cancer	0.000145	0.0017	CcSEcCtD
Orphenadrine—Asthenia—Doxorubicin—lung cancer	0.000144	0.00169	CcSEcCtD
Orphenadrine—Pruritus—Doxorubicin—lung cancer	0.000142	0.00167	CcSEcCtD
Orphenadrine—Nausea—Methotrexate—lung cancer	0.000137	0.00162	CcSEcCtD
Orphenadrine—Dizziness—Doxorubicin—lung cancer	0.000132	0.00156	CcSEcCtD
Orphenadrine—Vomiting—Doxorubicin—lung cancer	0.000127	0.0015	CcSEcCtD
Orphenadrine—Headache—Doxorubicin—lung cancer	0.000125	0.00148	CcSEcCtD
Orphenadrine—Nausea—Doxorubicin—lung cancer	0.000119	0.0014	CcSEcCtD
Orphenadrine—Imipramine—CYP2E1—lung cancer	0.000116	0.0187	CrCbGaD
Orphenadrine—Amitriptyline—CYP2E1—lung cancer	0.000116	0.0186	CrCbGaD
Orphenadrine—Trimipramine—ABCB1—lung cancer	8.23e-05	0.0133	CrCbGaD
Orphenadrine—Promethazine—ABCB1—lung cancer	7.92e-05	0.0128	CrCbGaD
Orphenadrine—Tamoxifen—ABCB1—lung cancer	7.87e-05	0.0127	CrCbGaD
Orphenadrine—Doxepin—ABCB1—lung cancer	7.84e-05	0.0126	CrCbGaD
Orphenadrine—Methadone—ABCB1—lung cancer	7.8e-05	0.0126	CrCbGaD
Orphenadrine—Amitriptyline—ALB—lung cancer	6.36e-05	0.0102	CrCbGaD
Orphenadrine—Imipramine—ABCB1—lung cancer	6.1e-05	0.00983	CrCbGaD
Orphenadrine—Amitriptyline—ABCB1—lung cancer	6.07e-05	0.00977	CrCbGaD
Orphenadrine—HRH1—Signaling Pathways—ANXA1—lung cancer	1.55e-05	8.66e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ANXA1—lung cancer	1.52e-05	8.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FLT1—lung cancer	1.5e-05	8.38e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CG—lung cancer	1.48e-05	8.31e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FLT1—lung cancer	1.47e-05	8.25e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM2—lung cancer	1.47e-05	8.24e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CNDP2—lung cancer	1.47e-05	8.24e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APP—lung cancer	1.47e-05	8.21e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOTCH3—lung cancer	1.47e-05	8.21e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CG—lung cancer	1.46e-05	8.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGF9—lung cancer	1.45e-05	8.14e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP2E1—lung cancer	1.45e-05	8.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APP—lung cancer	1.44e-05	8.08e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOTCH3—lung cancer	1.44e-05	8.08e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTMR3—lung cancer	1.43e-05	8.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGF9—lung cancer	1.43e-05	8.01e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NQO1—lung cancer	1.43e-05	8e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—POMC—lung cancer	1.41e-05	7.91e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NQO1—lung cancer	1.4e-05	7.84e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PGAM1—lung cancer	1.39e-05	7.81e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—POMC—lung cancer	1.39e-05	7.78e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JUNB—lung cancer	1.39e-05	7.77e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JUNB—lung cancer	1.37e-05	7.65e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CG—lung cancer	1.35e-05	7.54e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2A7—lung cancer	1.33e-05	7.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CG—lung cancer	1.33e-05	7.42e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CD—lung cancer	1.3e-05	7.3e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SDC4—lung cancer	1.3e-05	7.29e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—STK11—lung cancer	1.29e-05	7.21e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CD—lung cancer	1.28e-05	7.19e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—POMC—lung cancer	1.28e-05	7.18e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—STK11—lung cancer	1.26e-05	7.07e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—POMC—lung cancer	1.26e-05	7.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STK11—lung cancer	1.26e-05	7.06e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6R—lung cancer	1.25e-05	7e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STK11—lung cancer	1.24e-05	6.94e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6R—lung cancer	1.23e-05	6.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FOXO3—lung cancer	1.22e-05	6.81e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FOXO3—lung cancer	1.2e-05	6.7e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTP1—lung cancer	1.19e-05	6.68e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	1.19e-05	6.68e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—RRM1—lung cancer	1.19e-05	6.64e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTA3—lung cancer	1.19e-05	6.64e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	1.18e-05	6.63e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	1.17e-05	6.57e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTP1—lung cancer	1.17e-05	6.54e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	1.17e-05	6.52e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CAT—lung cancer	1.16e-05	6.5e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AVP—lung cancer	1.14e-05	6.38e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	1.14e-05	6.36e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CAT—lung cancer	1.14e-05	6.36e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCB1—lung cancer	1.13e-05	6.32e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AVP—lung cancer	1.12e-05	6.28e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	1.12e-05	6.26e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.11e-05	6.24e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TYMS—lung cancer	1.11e-05	6.21e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCB1—lung cancer	1.11e-05	6.19e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1R—lung cancer	1.1e-05	6.14e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—lung cancer	1.1e-05	6.13e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	1.09e-05	6.12e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TYMS—lung cancer	1.09e-05	6.08e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTA4—lung cancer	1.08e-05	6.07e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1R—lung cancer	1.08e-05	6.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HES1—lung cancer	1.08e-05	6.04e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	1.07e-05	6.02e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—lung cancer	1.07e-05	6.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HES1—lung cancer	1.06e-05	5.94e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—RAF1—lung cancer	1.06e-05	5.92e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTA2—lung cancer	1.06e-05	5.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2—lung cancer	1.04e-05	5.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—RAF1—lung cancer	1.04e-05	5.83e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP1A1—lung cancer	1.04e-05	5.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	1.03e-05	5.78e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ERCC2—lung cancer	1.03e-05	5.77e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2—lung cancer	1.03e-05	5.75e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTA1—lung cancer	1.02e-05	5.71e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP1A1—lung cancer	1.02e-05	5.7e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	1.02e-05	5.69e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ERCC2—lung cancer	1.01e-05	5.65e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCC3—lung cancer	1.01e-05	5.64e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL8—lung cancer	9.92e-06	5.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB3—lung cancer	9.86e-06	5.52e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKR1C1—lung cancer	9.76e-06	5.47e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL8—lung cancer	9.76e-06	5.47e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB3—lung cancer	9.7e-06	5.43e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2—lung cancer	9.48e-06	5.31e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—UGT1A1—lung cancer	9.48e-06	5.31e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TERT—lung cancer	9.45e-06	5.29e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2—lung cancer	9.33e-06	5.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TERT—lung cancer	9.29e-06	5.2e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGFR1—lung cancer	9.17e-06	5.14e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GNG11—lung cancer	9.14e-06	5.12e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HIF1A—lung cancer	9.03e-06	5.06e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGFR1—lung cancer	9.03e-06	5.05e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOA1—lung cancer	8.91e-06	4.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HIF1A—lung cancer	8.89e-06	4.98e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOA1—lung cancer	8.73e-06	4.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOA1—lung cancer	8.72e-06	4.88e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALDOA—lung cancer	8.7e-06	4.87e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KDR—lung cancer	8.64e-06	4.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOA1—lung cancer	8.58e-06	4.8e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KDR—lung cancer	8.5e-06	4.76e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOA3—lung cancer	8.45e-06	4.73e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ADCY1—lung cancer	8.22e-06	4.6e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCG2—lung cancer	8.22e-06	4.6e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CG—lung cancer	8.14e-06	4.56e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HPGDS—lung cancer	8.06e-06	4.51e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ENO2—lung cancer	8.06e-06	4.51e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPP2R1B—lung cancer	8.01e-06	4.48e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CG—lung cancer	7.97e-06	4.46e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CG—lung cancer	7.96e-06	4.46e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KIT—lung cancer	7.96e-06	4.46e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APC—lung cancer	7.96e-06	4.46e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—NRAS—lung cancer	7.96e-06	4.46e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGF—lung cancer	7.87e-06	4.4e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KIT—lung cancer	7.83e-06	4.38e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APC—lung cancer	7.83e-06	4.38e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CG—lung cancer	7.83e-06	4.38e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—NRAS—lung cancer	7.83e-06	4.38e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTT1—lung cancer	7.82e-06	4.38e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—POMC—lung cancer	7.74e-06	4.34e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGF—lung cancer	7.74e-06	4.33e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GCLC—lung cancer	7.73e-06	4.33e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2A6—lung cancer	7.73e-06	4.33e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK3—lung cancer	7.62e-06	4.27e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—POMC—lung cancer	7.59e-06	4.25e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—POMC—lung cancer	7.58e-06	4.24e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CREBBP—lung cancer	7.54e-06	4.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK3—lung cancer	7.5e-06	4.2e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BRAF—lung cancer	7.48e-06	4.19e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—POMC—lung cancer	7.45e-06	4.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6R—lung cancer	7.39e-06	4.14e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CREBBP—lung cancer	7.39e-06	4.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CREBBP—lung cancer	7.38e-06	4.13e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BRAF—lung cancer	7.36e-06	4.12e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ENO1—lung cancer	7.32e-06	4.1e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6R—lung cancer	7.27e-06	4.07e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CREBBP—lung cancer	7.26e-06	4.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—lung cancer	7.25e-06	4.06e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CD—lung cancer	7.15e-06	4e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—lung cancer	7.13e-06	3.99e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—lung cancer	7.06e-06	3.95e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAP2K1—lung cancer	7.04e-06	3.94e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CD—lung cancer	7.01e-06	3.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CD—lung cancer	7e-06	3.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	6.93e-06	3.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAP2K1—lung cancer	6.93e-06	3.88e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—lung cancer	6.92e-06	3.87e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CD—lung cancer	6.88e-06	3.85e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—KRAS—lung cancer	6.85e-06	3.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	6.82e-06	3.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—KRAS—lung cancer	6.74e-06	3.77e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2E1—lung cancer	6.57e-06	3.68e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NQO1—lung cancer	6.5e-06	3.64e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	6.29e-06	3.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MDM2—lung cancer	6.27e-06	3.51e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RAF1—lung cancer	6.25e-06	3.5e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CB—lung cancer	6.23e-06	3.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	6.19e-06	3.47e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB2—lung cancer	6.18e-06	3.46e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—lung cancer	6.18e-06	3.46e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MDM2—lung cancer	6.17e-06	3.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RAF1—lung cancer	6.15e-06	3.44e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CB—lung cancer	6.11e-06	3.42e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MTOR—lung cancer	6.1e-06	3.41e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CB—lung cancer	6.1e-06	3.41e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB2—lung cancer	6.08e-06	3.4e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—lung cancer	6.05e-06	3.39e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CB—lung cancer	6e-06	3.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MTOR—lung cancer	6e-06	3.36e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL8—lung cancer	5.86e-06	3.28e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—STK11—lung cancer	5.86e-06	3.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRAS—lung cancer	5.82e-06	3.26e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL8—lung cancer	5.77e-06	3.23e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRAS—lung cancer	5.73e-06	3.21e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—lung cancer	5.66e-06	3.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—lung cancer	5.61e-06	3.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2—lung cancer	5.6e-06	3.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—lung cancer	5.57e-06	3.12e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	5.57e-06	3.12e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—lung cancer	5.52e-06	3.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2—lung cancer	5.51e-06	3.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—lung cancer	5.48e-06	3.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCND1—lung cancer	5.46e-06	3.06e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JUN—lung cancer	5.45e-06	3.05e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTP1—lung cancer	5.42e-06	3.03e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTEN—lung cancer	5.39e-06	3.02e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCND1—lung cancer	5.37e-06	3.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JUN—lung cancer	5.36e-06	3e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—lung cancer	5.3e-06	2.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1A—lung cancer	5.28e-06	2.96e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTEN—lung cancer	5.28e-06	2.95e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CAT—lung cancer	5.27e-06	2.95e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTEN—lung cancer	5.27e-06	2.95e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—lung cancer	5.22e-06	2.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	5.2e-06	2.91e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTEN—lung cancer	5.19e-06	2.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—lung cancer	5.14e-06	2.88e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—EP300—lung cancer	5.14e-06	2.88e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCB1—lung cancer	5.13e-06	2.87e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—lung cancer	5.06e-06	2.83e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TYMS—lung cancer	5.04e-06	2.82e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—EP300—lung cancer	5.03e-06	2.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EP300—lung cancer	5.03e-06	2.81e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—lung cancer	4.98e-06	2.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EP300—lung cancer	4.95e-06	2.77e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SRC—lung cancer	4.89e-06	2.74e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SRC—lung cancer	4.81e-06	2.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—lung cancer	4.76e-06	2.66e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP1A1—lung cancer	4.72e-06	2.64e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT3—lung cancer	4.71e-06	2.64e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NRAS—lung cancer	4.7e-06	2.63e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—lung cancer	4.68e-06	2.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ERCC2—lung cancer	4.68e-06	2.62e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT3—lung cancer	4.64e-06	2.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NRAS—lung cancer	4.63e-06	2.59e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK3—lung cancer	4.5e-06	2.52e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK3—lung cancer	4.43e-06	2.48e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—lung cancer	4.38e-06	2.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—lung cancer	4.31e-06	2.41e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—lung cancer	4.28e-06	2.4e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—lung cancer	4.21e-06	2.36e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA1—lung cancer	4.05e-06	2.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KRAS—lung cancer	4.05e-06	2.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KRAS—lung cancer	3.98e-06	2.23e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CA—lung cancer	3.8e-06	2.13e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CA—lung cancer	3.72e-06	2.08e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CA—lung cancer	3.72e-06	2.08e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.7e-06	2.07e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	3.66e-06	2.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—lung cancer	3.6e-06	2.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—lung cancer	3.54e-06	1.98e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—POMC—lung cancer	3.52e-06	1.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRAS—lung cancer	3.44e-06	1.93e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CREBBP—lung cancer	3.43e-06	1.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRAS—lung cancer	3.38e-06	1.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—lung cancer	3.29e-06	1.84e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CD—lung cancer	3.25e-06	1.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—lung cancer	3.24e-06	1.81e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—lung cancer	3.21e-06	1.8e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—lung cancer	3.1e-06	1.74e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—lung cancer	3.04e-06	1.7e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—lung cancer	3.04e-06	1.7e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—lung cancer	2.99e-06	1.67e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.83e-06	1.59e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—lung cancer	2.81e-06	1.57e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTEN—lung cancer	2.45e-06	1.37e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—EP300—lung cancer	2.33e-06	1.31e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.73e-06	9.67e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—lung cancer	1.41e-06	7.9e-06	CbGpPWpGaD
